117 related articles for article (PubMed ID: 8671624)
1. Molecular cloning of murine decay accelerating factor by immunoscreening.
Fukuoka Y; Yasui A; Okada N; Okada H
Int Immunol; 1996 Mar; 8(3):379-85. PubMed ID: 8671624
[TBL] [Abstract][Full Text] [Related]
2. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
[TBL] [Abstract][Full Text] [Related]
3. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
4. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
[TBL] [Abstract][Full Text] [Related]
5. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
Harris CL; Pettigrew DM; Lea SM; Morgan BP
J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
[TBL] [Abstract][Full Text] [Related]
6. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
8. A new repetitive sequence uniquely present in the decay-accelerating factor genes.
Nonaka M; Takenaka O; Okada N; Okada H
Immunogenetics; 1998; 47(3):246-55. PubMed ID: 9435343
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.
Spicer AP; Seldin MF; Gendler SJ
J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).
Mead R; Hinchliffe SJ; Morgan BP
Immunology; 1999 Sep; 98(1):137-43. PubMed ID: 10469244
[TBL] [Abstract][Full Text] [Related]
11. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
[TBL] [Abstract][Full Text] [Related]
12. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
[TBL] [Abstract][Full Text] [Related]
13. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
[TBL] [Abstract][Full Text] [Related]
15. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.
Miwa T; Sun X; Ohta R; Okada N; Harris CL; Morgan BP; Song WC
Immunology; 2001 Oct; 104(2):207-14. PubMed ID: 11683961
[TBL] [Abstract][Full Text] [Related]
16. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
Kim DD; Miwa T; Song WC
J Immunol; 2006 Oct; 177(8):5558-66. PubMed ID: 17015743
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
19. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of the rat complement regulatory protein, 5I2 antigen.
Sakurada C; Seno H; Dohi N; Takizawa H; Nonaka M; Okada N; Okada H
Biochem Biophys Res Commun; 1994 Feb; 198(3):819-26. PubMed ID: 8117286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
